All — ST PHARM

Science & Technology
- Business Overview사업영역
- CDMO위탁생산개발
- CRO위탁임상서비스
  - AnaPath Research & Service
- R&D연구개발
  - Virtual R&D
  - Global R&D
About
Public
- PR (Public Relations)
  - News room
- IR (Investor Relations)
  - Stock Information
  - IR Library
Careers
ESG

Linkedin

Public

All

PR (Public Relations)
- News room
IR (Investor Relations)
- Stock Information
- IR Library

ST PHARM's Public Release

ST PHARM News에스티팜, 혁신형 제약기업 4회 연속 재인증Jul 16, 2024

ST PHARM News에스티팜 신임 대표이사 성무제 사장 선임Jun 19, 2024

ST PHARM News[에스티팜, 2024 DCAT Week 참가] 美서 글로벌 경쟁력 선보여Mar 20, 2024

ST PHARM News[안내] RNA Innovation Symposium Corea/Korea 2024 (RISC 2024) 개최Feb 26, 2024

ST PHARM News[안내] 에스티팜, Pirmitegravir(STP0404), HIV: Three trials to watch in 2024Jan 15, 2024

ST PHARM NewsST Pharm Webinar Series: mRNA TechnologiesDec 14, 2023

ST PHARM News[Tides Europe 2023] Exploring Excellence in Oligonucleotide CDMO services at ST PharmDec 14, 2023

ST PHARM News[2023 제약바이오포럼] 최석우 에스티팜 본부장 "글로벌 CDMO 시장 성장 드라이브"Nov 21, 2023

ST PHARM News[World Bio Summit 2023 행사] '자체 mRNA 플랫폼 기술을 적용한 100일 신속 백신 생산 및 공급 전략' 발표Nov 21, 2023

ST PHARM NewsInvesting in mRNA platforms to create CDMO-biotech partnership opportunitiesNov 13, 2023

ST PHARM News국제백신연구소(IVI International Vaccine Institute) 이사회 방문Nov 9, 2023

ST PHARM News[안내] 'Beyond Open Innovation' 프로모션 행사 (SmartCap® SC101 & SC103)Oct 18, 2023

ST PHARM News[안내] 에스티팜 해외 전시회/학회 참석 정보Oct 14, 2023

2of28